Navigation Links
Amnis Announces Record 2009 Sales
Date:2/11/2010

SEATTLE, Feb. 11 /PRNewswire/ -- Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced record 2009 sales results. The successful launch of the ImageStreamX imaging flow cytometer resulted in annual sales growth in excess of 75% and the company's first cash flow positive quarter.  Strong early sales for the new instrument consumed the company's manufacturing capacity for 2009 and well into 2010.

"We designed the new ImageStreamX platform to be ten times faster and much more powerful than the product it replaces while lowering the price by nearly a third. Given this tremendous value proposition, we expected an uptick in sales but our expectations were tempered by the difficult economic conditions throughout 2009," said David Basiji, Ph.D., Amnis' President and Chief Executive Officer. Basiji added, "Needless to say, we're thrilled with 75% sales growth in 2009 and we continue to see strong demand in early 2010."

"We've crossed the cash flow break even point and we're looking at full year profitability in 2010," remarked William Ortyn, Amnis' co-founder and Chief Operating Officer.  "The ImageStreamX has crossed several performance thresholds opening new market segments for Amnis," added Ortyn.

About Amnis: Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets instrumentation for high speed cell imaging for research and diagnostic markets. The ImageStream system, introduced in 2005, is in service in over 15 countries world-wide. Researchers have utilized ImageStream technology to produce over 100 groundbreaking scientific publications. (www.amnis.com)

SOURCE Amnis Corporation

RELATED LINKS
http://www.amnis.com

'/>"/>

SOURCE Amnis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amnis to Present at the 28th Annual J.P. Morgan Healthcare Conference
2. Amnis Begins Shipment of New ImageStreamX Imaging Flow Cytometers
3. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
4. The American Academy of Pain Medicine Announces this Years Presidential Commendations and Awards
5. CORD:USE Cord Blood Bank Announces Partnership with Memorial Healthcare System
6. Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
7. Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
8. Kensey Nash Announces $30 Million Share Buyback
9. Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators
10. ISTA Pharmaceuticals Announces 2010 Financial Guidance
11. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... -- Boston Scientific Corporation (NYSE: BSX ) ... assets and capabilities of the Neovasc, Inc., (NASDAQ: ... as well as a 15% equity stake in Neovasc, ... Neovasc advanced biological tissue business makes elements used in ... System. * Upon completion of the transaction, the ...
Breaking Medicine Technology:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... On Dec. ... the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have ... (MPNs) by going above and beyond the standard of care, demonstrating leadership within the ...
(Date:12/2/2016)... ... ... Advanced Inc., a leading provider of travel therapy and travel nursing across ... Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as Vice ... leadership experience to Advanced Inc. He began his career in finance at Ernst & ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... interview of two ostomy patients, standing as living proof that attitude and determination ... digestive diseases and issues that spike around the holidays. This campaign will offer ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Health" in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized ... fulfilling lives. “We are prolonging life 6 years in the last 3 decades,” ...
Breaking Medicine News(10 mins):